1. Home
  2. Amyloid beta
  Subject:

Amyloid beta   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Protein  13 times
Memory  13 times
Dementia  11 times
Apolipoprotein  10 times
Positron  9 times
Amyloid precursor protein  9 times
Metabolism  7 times
Hippocampus  7 times
Cerebrospinal fluid  7 times
Peptide  6 times
Oxidative stress  6 times
Mild cognitive impairment  6 times
Magnetic resonance imaging  6 times
Biomarker  6 times
Homeostasis  5 times
Central nervous system  5 times
Blood plasma  5 times
Acid  5 times
Neuropathology  4 times
Lipoprotein  4 times
Genetically modified mouse  4 times
Enzyme  4 times
Blood–brain barrier  4 times
Western blot  3 times
Prefrontal cortex  3 times
Precuneus  3 times
Phosphorylation  3 times
Oligomer  3 times
Neurotoxicity  3 times
Neurogenesis  3 times
Neurodegeneration  3 times
Mouse  3 times
Glucose  3 times
Flow cytometry  3 times
Cingulate cortex  3 times
Amyloid precursor protein secretase  3 times
White matter  2 times
Synaptic plasticity  2 times
Reactive oxygen species  2 times
Progressive supranuclear palsy  2 times
Positron emission tomography  2 times
Phospholipid  2 times
Phospholipase A2  2 times
Neurotrophic factors  2 times
Neuron  2 times
Mutation  2 times
Microglia  2 times
Lipid  2 times
Hormone  2 times
Glycine  2 times
Glycation  2 times
Fatty acid  2 times
Cytokine  2 times
Critical Role  2 times
Cerebellum  2 times
Cell surface receptor  2 times
Basal ganglia  2 times
Apoptosis  2 times
Amnesia  2 times
Albumin  2 times
Agonist  2 times
Zygosity  1 time
Zinc  1 time
Zebrafish  1 time
Vitamin A  1 time
Virtual screening  1 time
University of Pittsburgh  1 time
Triiodothyronine  1 time
Traditional Chinese medicine  1 time
Toll-like receptor  1 time
Thyroid hormones  1 time
Thylakoid  1 time
Threonine  1 time
Thalamus  1 time
Telomere  1 time
Tauopathy  1 time
T helper cell  1 time
T cell  1 time
Synuclein  1 time
Syndrome  1 time
Synapse  1 time
Swedish language  1 time
Surface plasmon resonance  1 time
Surface plasmon  1 time
Substantia nigra  1 time
Streptozotocin  1 time
Stenosis  1 time
Statistical power  1 time
Sport utility vehicle  1 time
Spinal cord injury  1 time
Single-photon emission computed tomography  1 time
Serine  1 time
Senescence  1 time
S-Adenosyl methionine  1 time
Rosiglitazone  1 time
Rodent  1 time
Regression analysis  1 time
Reference model  1 time
Red blood cell  1 time
Purine  1 time
PubMed  1 time
Proton  1 time
Proteomics  1 time
Protein kinase B  1 time
Protease  1 time
Prodrome  1 time
Postsynaptic density  1 time
Point mutation  1 time
Placebo  1 time
Pineal gland  1 time
Phosphoinositide 3-kinase  1 time
Phosphatidylserine  1 time
Phosphatidylinositol  1 time
Phenotype  1 time
Pharmacophore  1 time
Pharmacokinetics  1 time
Phagocytosis  1 time
Peroxisome proliferator-activated receptor  1 time
Peroxisome  1 time
Ovary  1 time
Nuclear medicine  1 time
Nuclear magnetic resonance  1 time
Nitric oxide  1 time
Nikola Tesla  1 time
Neuropsychological test  1 time
Neuroimaging  1 time
Naringenin  1 time
NFE2L2  1 time
NF-κB  1 time
Myelin  1 time
Multiple system atrophy  1 time
Multiple sclerosis  1 time
Monocyte  1 time
Monoamine oxidase  1 time
Mitochondrion  1 time
Mitochondrial permeability transition pore  1 time
Mini–Mental State Examination  1 time
Methionine  1 time
Melatonin  1 time
Matrix metalloproteinase  1 time
Major depressive disorder  1 time
Lymphocyte  1 time
Low-density lipoprotein  1 time
Long-term potentiation  1 time
Long-term memory  1 time
Logistic regression  1 time
Liposome  1 time
Lipid peroxidation  1 time
Lingzhi mushroom  1 time
Lateral ventricles  1 time
LY294002  1 time
Kinase  1 time
Iron oxide  1 time
Interleukin 10  1 time
Insulin resistance  1 time
Innate immune system  1 time
Immunoprecipitation  1 time
Immunohistochemistry  1 time
Immunofluorescence  1 time
Hypothalamus  1 time
Hypertension  1 time
Homocysteine  1 time
Heritability  1 time
Hamster  1 time
Half-life  1 time
Glial fibrillary acidic protein  1 time
Genome-wide association study  1 time
Gas chromatography  1 time
GSK-3  1 time
Frontotemporal dementia  1 time
Exosome complex  1 time
Excitotoxicity  1 time
Estrogen receptor  1 time
Epitope  1 time
Episodic memory  1 time
Enzyme inhibitor  1 time
Endothelium  1 time
Endoplasmic reticulum  1 time
Endocytosis  1 time
Electrophysiology  1 time
Edema  1 time
ELISA  1 time
Dopamine  1 time
Direct binding  1 time
Diffusion MRI  1 time
Diazepam  1 time
Diabetes mellitus type 2  1 time
Diabetes mellitus  1 time
Dentate gyrus  1 time
Decoction  1 time
DNA methylation  1 time
DNA  1 time
Cysteine  1 time
Cyclophilin  1 time
Common carotid artery  1 time
Clinical trial  1 time
Classical mechanics  1 time
Ciclosporin  1 time
Cerebrovascular disease  1 time
Caudate nucleus  1 time
Caspase 3  1 time
CT scan  1 time
Bromide  1 time
Brain-derived neurotrophic factor  1 time
Biosensor  1 time
Biomimetics  1 time
Biological half-life  1 time
Bioinformatics  1 time
Before Present  1 time
B cell  1 time
Autoradiograph  1 time
Autoimmune disease  1 time
Astrogliosis  1 time
Annexin  1 time
Amyloidosis  1 time
Amygdala  1 time
Amsterdam  1 time
Agranulocyte  1 time
Acetylcholinesterase  1 time

Publications tagged with this subject: 50

Note: Top 50 publications shown only. Open an item panel to view more info


1. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound

2. Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain

3. Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer’s disease: an exploration of underlying mechanisms

4. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer’s disease: analysis of Osaka mutation-knockin mice

5. Stress-Induced Alterations of Immune Profile in Animals Suffering by Tau Protein-Driven Neurodegeneration

6. Diurnal oscillation of CSF Aβ and other AD biomarkers

7. Identify a shared neural circuit linking multiple neuropsychiatric symptoms with Alzheimer’s pathology

8. Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging

9. Marginal vitamin A deficiency facilitates Alzheimer’s pathogenesis

10. Sorting nexin-4 regulates β-amyloid production by modulating β-site-activating cleavage enzyme-1

11. Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer’s disease

12. Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice

13. Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA2 balance

14. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner

15. Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice

16. Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response

17. Self-reported confusion is related to global and regional β-amyloid: data from the Women’s healthy ageing project

18. High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture

19. Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer’s disease

20. Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction

21. Aging and amyloid β oligomers enhance TLR4 expression, LPS-induced Ca2+ responses, and neuron cell death in cultured rat hippocampal neurons

22. Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data

23. The role of melatonin in the onset and progression of type 3 diabetes

24. Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

25. Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review

26. Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer’s Disease

27. Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer’s-Like Amyloid Pathology

28. Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s Disease

29. Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study

30. Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies

31. Therapeutic Potential of Baicalein in Alzheimer’s Disease and Parkinson’s Disease

32. Protective Role Of Naringenin Against Aβ25-35-Caused Damage via ER and PI3K/Akt-Mediated Pathways

33. A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting

34. RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model

35. Binding of 11C-Pittsburgh compound-B correlated with white matter injury in hypertensive small vessel disease

36. The Research on the Relationship of RAGE, LRP-1, and Aβ Accumulation in the Hippocampus, Prefrontal Lobe, and Amygdala of STZ-Induced Diabetic Rats

37. β-Amyloid Biomarker Detection for Alzheimer’s Disease

38. Low-Density Lipoprotein Receptor-Related Protein-1 (LRP1) C4408R Mutant Promotes Amyloid Precursor Protein (APP) α-Cleavage in Vitro

39. Association of cortical B-amyloid with erythrocyte membrane monounsaturated and saturated fatty acids in older adults at risk of dementia

40. A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome

41. Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts

42. Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment

43. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition

44. Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases

45. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond

46. Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer’s disease pathogenesis

47. Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation

48. Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers

49. MMP-7 cleaves amyloid β fragment peptides and copper ion inhibits the degradation

50. The role of exosomes in the pathogenesis of Alzheimer’ disease


Questions?

Drop us a message.